3D-PRINTED FLOATING DRUG DELIVERY SYSTEMS: PRINCIPLES, TECHNOLOGIES, FORMULATION STRATEGIES AND FUTURE PERSPECTIVES

Abstract Floating drug delivery systems (FDDS) are gastroretentive oral dosage forms designed to remain buoyant in the stomach and prolong gastric residence. They are particularly useful for drugs with a narrow absorption window in the upper gastrointestinal tract, limited intestinal solubility, short biological half-life, or a requirement for local gastric action. However, conventional FDDS are influenced by gastric physiology, fixed dosage designs, limited dose flexibility, and manufacturing challenges Three-dimensional (3D) printing is an additive manufacturing technology that enables precise control over dosage-form geometry, internal architecture, porosity, density, drug loading, and drug-release characteristics. This review discusses the principles and classification of FDDS and explores their integration with 3D printing. Major pharmaceutical printing techniques, including fused deposition modelling (FDM), semi-solid extrusion (SSE), selective laser sintering (SLS), thermal inkjet printing, and binder jetting, are reviewed with emphasis on their applicability to gastroretentive systems. 3D-printed gastroretentive systems have demonstrated rapid buoyancy, prolonged and controlled drug release, customized dosage-form geometry, and the potential for patient-specific dosing. These approaches provide greater flexibility in designing floating systems compared with conventional manufacturing methods. Despite these advantages, challenges related to printable materials, thermal or solvent exposure, drug-loading capacity, dimensional accuracy, scale-up, quality control, reproducibility, and regulatory requirements remain. Advances in pharmaceutical materials, digital design, process monitoring, and predictive modelling may facilitate the translation of 3D-printed FDDS into personalized oral drug delivery. Keywords: 3D printing; additive manufacturing; floating drug delivery system; gastroretentive drug delivery; personalized medicine

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-09-26
DOI
https://doi.org/10.5281/zenodo.22975256
Primary Topic
3D Printing in Biomedical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

3D-PRINTED FLOATING DRUG DELIVERY SYSTEMS: PRINCIPLES, TECHNOLOGIES, FORMULATION STRATEGIES AND FUTURE PERSPECTIVES

Pisipati Aparna, B Vani hepsiba, B Aruna, Dr. Y.A. Chowdary et al.
Zenodo (CERN European Organization for Nuclear Research)
3D Printing in Biomedical Research
article

3D-PRINTED FLOATING DRUG DELIVERY SYSTEMS: PRINCIPLES, TECHNOLOGIES, FORMULATION STRATEGIES AND FUTURE PERSPECTIVES

Pisipati Aparna, B Vani hepsiba, B Aruna, Dr. Y.A. Chowdary, Dr. Garlapati Usha Kiran
article en

Abstract

Abstract Floating drug delivery systems (FDDS) are gastroretentive oral dosage forms designed to remain buoyant in the stomach and prolong gastric residence. They are particularly useful for drugs with a narrow absorption window in the upper gastrointestinal tract, limited intestinal solubility, short biological half-life, or a requirement for local gastric action. However, conventional FDDS are influenced by gastric physiology, fixed dosage designs, limited dose flexibility, and manufacturing challenges Three-dimensional (3D) printing is an additive manufacturing technology that enables precise control over dosage-form geometry, internal architecture, porosity, density, drug loading, and drug-release characteristics. This review discusses the principles and classification of FDDS and explores their integration with 3D printing. Major pharmaceutical printing techniques, including fused deposition modelling (FDM), semi-solid extrusion (SSE), selective laser sintering (SLS), thermal inkjet printing, and binder jetting, are reviewed with emphasis on their applicability to gastroretentive systems. 3D-printed gastroretentive systems have demonstrated rapid buoyancy, prolonged and controlled drug release, customized dosage-form geometry, and the potential for patient-specific dosing. These approaches provide greater flexibility in designing floating systems compared with conventional manufacturing methods. Despite these advantages, challenges related to printable materials, thermal or solvent exposure, drug-loading capacity, dimensional accuracy, scale-up, quality control, reproducibility, and regulatory requirements remain. Advances in pharmaceutical materials, digital design, process monitoring, and predictive modelling may facilitate the translation of 3D-printed FDDS into personalized oral drug delivery. Keywords: 3D printing; additive manufacturing; floating drug delivery system; gastroretentive drug delivery; personalized medicine

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 21%
3D Printing in Biomedical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

3D-PRINTED FLOATING DRUG DELIVERY SYSTEMS: PRINCIPLES, TECHNOLOGIES, FORMULATION STRATEGIES AND FUTURE PERSPECTIVES — Pisipati Aparna, B Vani hepsiba, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS